Infanrix Hexa 25 mcg

Infanrix Hexa 25 mcg is a hexavalent vaccine designed to protect against six diseases. This suspension is administered intramuscularly and is manufactured by GlaxoSmithKline Inc. in Canada.

Infanrix Hexa 25 mcg is used to provide immunity against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b. This vaccine is typically administered to infants and young children to help prevent these serious infections. The primary use of Infanrix Hexa is to support the immune system in developing protection against these diseases.

Common effects of Infanrix Hexa 25 mcg may include mild redness, swelling, or pain at the injection site. Some individuals may experience fever, irritability, or loss of appetite. These effects are generally mild and temporary, resolving within a few days.

Infanrix Hexa 25 mcg should be administered by a healthcare professional. It is important to inform the healthcare provider about any allergies or medical conditions before receiving the vaccine. The vaccine should be stored and handled according to the manufacturer's guidelines to ensure its effectiveness.

Infanrix Hexa 25 mcg may interact with other medications or vaccines. It is important to discuss any current medications or recent vaccinations with a healthcare provider before receiving this vaccine. Additionally, individuals with a history of severe allergic reactions to any component of the vaccine should avoid receiving it.